nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenylephrine—Eye irritation—Lovastatin—atherosclerosis	0.0144	0.0287	CcSEcCtD
Phenylephrine—Neck pain—Ezetimibe—atherosclerosis	0.0122	0.0244	CcSEcCtD
Phenylephrine—Skin exfoliation—Niacin—atherosclerosis	0.0101	0.0201	CcSEcCtD
Phenylephrine—Orthostatic hypotension—Niacin—atherosclerosis	0.00701	0.014	CcSEcCtD
Phenylephrine—Arrhythmia—Rosuvastatin—atherosclerosis	0.00652	0.013	CcSEcCtD
Phenylephrine—Mental disorder—Rosuvastatin—atherosclerosis	0.00639	0.0127	CcSEcCtD
Phenylephrine—Sweating increased—Pravastatin—atherosclerosis	0.00636	0.0127	CcSEcCtD
Phenylephrine—Acute coronary syndrome—Pravastatin—atherosclerosis	0.00574	0.0114	CcSEcCtD
Phenylephrine—Myocardial infarction—Pravastatin—atherosclerosis	0.00571	0.0114	CcSEcCtD
Phenylephrine—Angiopathy—Ezetimibe—atherosclerosis	0.0055	0.011	CcSEcCtD
Phenylephrine—Immune system disorder—Ezetimibe—atherosclerosis	0.00548	0.0109	CcSEcCtD
Phenylephrine—Mediastinal disorder—Ezetimibe—atherosclerosis	0.00547	0.0109	CcSEcCtD
Phenylephrine—Mental disorder—Ezetimibe—atherosclerosis	0.00531	0.0106	CcSEcCtD
Phenylephrine—Dysgeusia—Lovastatin—atherosclerosis	0.00527	0.0105	CcSEcCtD
Phenylephrine—Visual impairment—Niacin—atherosclerosis	0.00512	0.0102	CcSEcCtD
Phenylephrine—Nervous system disorder—Rosuvastatin—atherosclerosis	0.00508	0.0101	CcSEcCtD
Phenylephrine—Vision blurred—Lovastatin—atherosclerosis	0.00507	0.0101	CcSEcCtD
Phenylephrine—Mental disorder—Simvastatin—atherosclerosis	0.00507	0.0101	CcSEcCtD
Phenylephrine—Tremor—Lovastatin—atherosclerosis	0.00504	0.0101	CcSEcCtD
Phenylephrine—Visual impairment—Pravastatin—atherosclerosis	0.00504	0.01	CcSEcCtD
Phenylephrine—Dysgeusia—Simvastatin—atherosclerosis	0.00493	0.00983	CcSEcCtD
Phenylephrine—Cardiac disorder—Pravastatin—atherosclerosis	0.00485	0.00967	CcSEcCtD
Phenylephrine—Angiopathy—Niacin—atherosclerosis	0.00482	0.0096	CcSEcCtD
Phenylephrine—Vision blurred—Simvastatin—atherosclerosis	0.00474	0.00946	CcSEcCtD
Phenylephrine—Arrhythmia—Niacin—atherosclerosis	0.00474	0.00945	CcSEcCtD
Phenylephrine—Tremor—Simvastatin—atherosclerosis	0.00472	0.0094	CcSEcCtD
Phenylephrine—Arrhythmia—Pravastatin—atherosclerosis	0.00467	0.00931	CcSEcCtD
Phenylephrine—Palpitations—Ezetimibe—atherosclerosis	0.00466	0.0093	CcSEcCtD
Phenylephrine—Paraesthesia—Rosuvastatin—atherosclerosis	0.00465	0.00928	CcSEcCtD
Phenylephrine—Chest pain—Lovastatin—atherosclerosis	0.00458	0.00913	CcSEcCtD
Phenylephrine—Hypertension—Ezetimibe—atherosclerosis	0.00456	0.00908	CcSEcCtD
Phenylephrine—Tension—Niacin—atherosclerosis	0.00454	0.00904	CcSEcCtD
Phenylephrine—Chest pain—Ezetimibe—atherosclerosis	0.00449	0.00896	CcSEcCtD
Phenylephrine—Nervousness—Niacin—atherosclerosis	0.00449	0.00895	CcSEcCtD
Phenylephrine—Tension—Pravastatin—atherosclerosis	0.00447	0.0089	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.00446	0.0089	CcSEcCtD
Phenylephrine—Dysgeusia—Pravastatin—atherosclerosis	0.00446	0.00888	CcSEcCtD
Phenylephrine—Pain—Rosuvastatin—atherosclerosis	0.00443	0.00883	CcSEcCtD
Phenylephrine—Nervousness—Pravastatin—atherosclerosis	0.00442	0.00881	CcSEcCtD
Phenylephrine—Vision blurred—Niacin—atherosclerosis	0.00436	0.00868	CcSEcCtD
Phenylephrine—Vision blurred—Pravastatin—atherosclerosis	0.00429	0.00855	CcSEcCtD
Phenylephrine—Chest pain—Simvastatin—atherosclerosis	0.00429	0.00854	CcSEcCtD
Phenylephrine—Tremor—Pravastatin—atherosclerosis	0.00426	0.0085	CcSEcCtD
Phenylephrine—Nervous system disorder—Ezetimibe—atherosclerosis	0.00422	0.00842	CcSEcCtD
Phenylephrine—Skin disorder—Ezetimibe—atherosclerosis	0.00418	0.00834	CcSEcCtD
Phenylephrine—Syncope—Niacin—atherosclerosis	0.00415	0.00826	CcSEcCtD
Phenylephrine—Urticaria—Rosuvastatin—atherosclerosis	0.00412	0.00821	CcSEcCtD
Phenylephrine—Palpitations—Niacin—atherosclerosis	0.00408	0.00814	CcSEcCtD
Phenylephrine—Loss of consciousness—Niacin—atherosclerosis	0.00406	0.0081	CcSEcCtD
Phenylephrine—Paraesthesia—Lovastatin—atherosclerosis	0.00394	0.00786	CcSEcCtD
Phenylephrine—Hypertension—Pravastatin—atherosclerosis	0.00393	0.00783	CcSEcCtD
Phenylephrine—Dyspnoea—Lovastatin—atherosclerosis	0.00392	0.00781	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.00391	0.00779	CcSEcCtD
Phenylephrine—Chest pain—Pravastatin—atherosclerosis	0.00387	0.00772	CcSEcCtD
Phenylephrine—Paraesthesia—Ezetimibe—atherosclerosis	0.00387	0.00771	CcSEcCtD
Phenylephrine—Dyspnoea—Ezetimibe—atherosclerosis	0.00384	0.00766	CcSEcCtD
Phenylephrine—Hypersensitivity—Rosuvastatin—atherosclerosis	0.00382	0.00761	CcSEcCtD
Phenylephrine—Pain—Lovastatin—atherosclerosis	0.00376	0.00749	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.00372	0.00741	CcSEcCtD
Phenylephrine—Shock—Niacin—atherosclerosis	0.00371	0.0074	CcSEcCtD
Phenylephrine—Paraesthesia—Simvastatin—atherosclerosis	0.00369	0.00735	CcSEcCtD
Phenylephrine—Pain—Ezetimibe—atherosclerosis	0.00368	0.00734	CcSEcCtD
Phenylephrine—Tachycardia—Niacin—atherosclerosis	0.00368	0.00734	CcSEcCtD
Phenylephrine—Pruritus—Rosuvastatin—atherosclerosis	0.00367	0.00731	CcSEcCtD
Phenylephrine—Skin disorder—Niacin—atherosclerosis	0.00366	0.0073	CcSEcCtD
Phenylephrine—Dyspnoea—Simvastatin—atherosclerosis	0.00366	0.0073	CcSEcCtD
Phenylephrine—Hyperhidrosis—Niacin—atherosclerosis	0.00365	0.00727	CcSEcCtD
Phenylephrine—Hyperhidrosis—Pravastatin—atherosclerosis	0.00359	0.00716	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.00355	0.00707	CcSEcCtD
Phenylephrine—Pain—Simvastatin—atherosclerosis	0.00351	0.007	CcSEcCtD
Phenylephrine—Urticaria—Lovastatin—atherosclerosis	0.00349	0.00696	CcSEcCtD
Phenylephrine—Dizziness—Rosuvastatin—atherosclerosis	0.00343	0.00683	CcSEcCtD
Phenylephrine—Urticaria—Ezetimibe—atherosclerosis	0.00342	0.00682	CcSEcCtD
Phenylephrine—Paraesthesia—Niacin—atherosclerosis	0.00339	0.00675	CcSEcCtD
Phenylephrine—Dyspnoea—Niacin—atherosclerosis	0.00336	0.0067	CcSEcCtD
Phenylephrine—Paraesthesia—Pravastatin—atherosclerosis	0.00334	0.00665	CcSEcCtD
Phenylephrine—Dyspnoea—Pravastatin—atherosclerosis	0.00331	0.0066	CcSEcCtD
Phenylephrine—Rash—Rosuvastatin—atherosclerosis	0.00327	0.00651	CcSEcCtD
Phenylephrine—Dermatitis—Rosuvastatin—atherosclerosis	0.00326	0.00651	CcSEcCtD
Phenylephrine—Urticaria—Simvastatin—atherosclerosis	0.00326	0.00651	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Niacin—atherosclerosis	0.00326	0.00649	CcSEcCtD
Phenylephrine—Headache—Rosuvastatin—atherosclerosis	0.00325	0.00647	CcSEcCtD
Phenylephrine—Hypersensitivity—Lovastatin—atherosclerosis	0.00324	0.00645	CcSEcCtD
Phenylephrine—Pain—Niacin—atherosclerosis	0.00323	0.00643	CcSEcCtD
Phenylephrine—Pain—Pravastatin—atherosclerosis	0.00318	0.00633	CcSEcCtD
Phenylephrine—Hypersensitivity—Ezetimibe—atherosclerosis	0.00317	0.00633	CcSEcCtD
Phenylephrine—Pruritus—Lovastatin—atherosclerosis	0.00311	0.00619	CcSEcCtD
Phenylephrine—Nausea—Rosuvastatin—atherosclerosis	0.00308	0.00614	CcSEcCtD
Phenylephrine—Pruritus—Ezetimibe—atherosclerosis	0.00305	0.00608	CcSEcCtD
Phenylephrine—Hypersensitivity—Simvastatin—atherosclerosis	0.00303	0.00603	CcSEcCtD
Phenylephrine—Urticaria—Niacin—atherosclerosis	0.003	0.00597	CcSEcCtD
Phenylephrine—Urticaria—Pravastatin—atherosclerosis	0.00295	0.00588	CcSEcCtD
Phenylephrine—Pruritus—Simvastatin—atherosclerosis	0.00291	0.00579	CcSEcCtD
Phenylephrine—Dizziness—Lovastatin—atherosclerosis	0.0029	0.00579	CcSEcCtD
Phenylephrine—Dizziness—Ezetimibe—atherosclerosis	0.00285	0.00568	CcSEcCtD
Phenylephrine—Vomiting—Lovastatin—atherosclerosis	0.00279	0.00557	CcSEcCtD
Phenylephrine—Hypersensitivity—Niacin—atherosclerosis	0.00278	0.00554	CcSEcCtD
Phenylephrine—Rash—Lovastatin—atherosclerosis	0.00277	0.00552	CcSEcCtD
Phenylephrine—Dermatitis—Lovastatin—atherosclerosis	0.00277	0.00552	CcSEcCtD
Phenylephrine—Headache—Lovastatin—atherosclerosis	0.00275	0.00548	CcSEcCtD
Phenylephrine—Vomiting—Ezetimibe—atherosclerosis	0.00274	0.00546	CcSEcCtD
Phenylephrine—Hypersensitivity—Pravastatin—atherosclerosis	0.00274	0.00545	CcSEcCtD
Phenylephrine—Dizziness—Simvastatin—atherosclerosis	0.00272	0.00542	CcSEcCtD
Phenylephrine—Rash—Ezetimibe—atherosclerosis	0.00272	0.00541	CcSEcCtD
Phenylephrine—Dermatitis—Ezetimibe—atherosclerosis	0.00271	0.00541	CcSEcCtD
Phenylephrine—Headache—Ezetimibe—atherosclerosis	0.0027	0.00538	CcSEcCtD
Phenylephrine—Pruritus—Niacin—atherosclerosis	0.00267	0.00532	CcSEcCtD
Phenylephrine—Pruritus—Pravastatin—atherosclerosis	0.00263	0.00524	CcSEcCtD
Phenylephrine—Vomiting—Simvastatin—atherosclerosis	0.00261	0.00521	CcSEcCtD
Phenylephrine—Nausea—Lovastatin—atherosclerosis	0.00261	0.0052	CcSEcCtD
Phenylephrine—Rash—Simvastatin—atherosclerosis	0.00259	0.00516	CcSEcCtD
Phenylephrine—Dermatitis—Simvastatin—atherosclerosis	0.00259	0.00516	CcSEcCtD
Phenylephrine—Headache—Simvastatin—atherosclerosis	0.00257	0.00513	CcSEcCtD
Phenylephrine—Nausea—Ezetimibe—atherosclerosis	0.00256	0.0051	CcSEcCtD
Phenylephrine—Dizziness—Niacin—atherosclerosis	0.00249	0.00497	CcSEcCtD
Phenylephrine—Dizziness—Pravastatin—atherosclerosis	0.00246	0.0049	CcSEcCtD
Phenylephrine—Nausea—Simvastatin—atherosclerosis	0.00244	0.00486	CcSEcCtD
Phenylephrine—Vomiting—Niacin—atherosclerosis	0.0024	0.00478	CcSEcCtD
Phenylephrine—Rash—Niacin—atherosclerosis	0.00238	0.00474	CcSEcCtD
Phenylephrine—Dermatitis—Niacin—atherosclerosis	0.00238	0.00474	CcSEcCtD
Phenylephrine—Headache—Niacin—atherosclerosis	0.00236	0.00471	CcSEcCtD
Phenylephrine—Vomiting—Pravastatin—atherosclerosis	0.00236	0.00471	CcSEcCtD
Phenylephrine—Rash—Pravastatin—atherosclerosis	0.00234	0.00467	CcSEcCtD
Phenylephrine—Dermatitis—Pravastatin—atherosclerosis	0.00234	0.00466	CcSEcCtD
Phenylephrine—Headache—Pravastatin—atherosclerosis	0.00233	0.00464	CcSEcCtD
Phenylephrine—Nausea—Niacin—atherosclerosis	0.00224	0.00447	CcSEcCtD
Phenylephrine—Nausea—Pravastatin—atherosclerosis	0.00221	0.0044	CcSEcCtD
Phenylephrine—ADRA1B—Signaling by GPCR—PRKCG—atherosclerosis	0.000189	0.000378	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—VWF—atherosclerosis	0.000188	0.000377	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—CNR2—atherosclerosis	0.000187	0.000375	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR ligand binding—CXCL8—atherosclerosis	0.000187	0.000375	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—MMP3—atherosclerosis	0.000187	0.000375	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—APOC3—atherosclerosis	0.000187	0.000374	CbGpPWpGaD
Phenylephrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atherosclerosis	0.000186	0.000374	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—LDLR—atherosclerosis	0.000185	0.000372	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—HMOX1—atherosclerosis	0.000185	0.000371	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—F2—atherosclerosis	0.000185	0.000371	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—PRKCG—atherosclerosis	0.000184	0.00037	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—AGT—atherosclerosis	0.000183	0.000367	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—CCL3—atherosclerosis	0.000181	0.000363	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	0.000179	0.000358	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—EDN1—atherosclerosis	0.000178	0.000356	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—APOB—atherosclerosis	0.000177	0.000356	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—PIK3CG—atherosclerosis	0.000177	0.000355	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—CCL5—atherosclerosis	0.000176	0.000354	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—NCF1—atherosclerosis	0.000173	0.000348	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—GSTM1—atherosclerosis	0.000172	0.000346	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—ABCG1—atherosclerosis	0.00017	0.000341	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—LPL—atherosclerosis	0.000169	0.00034	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—F2—atherosclerosis	0.000169	0.000339	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—KNG1—atherosclerosis	0.000169	0.000339	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—AGTR1—atherosclerosis	0.000168	0.000337	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—PRKCG—atherosclerosis	0.000167	0.000336	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—VWF—atherosclerosis	0.000167	0.000335	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—AGT—atherosclerosis	0.000166	0.000333	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—APOC3—atherosclerosis	0.000166	0.000333	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—GPX1—atherosclerosis	0.000165	0.000331	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—LDLR—atherosclerosis	0.000165	0.000331	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—CCL2—atherosclerosis	0.000165	0.00033	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—EDNRA—atherosclerosis	0.000164	0.000329	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—CCR2—atherosclerosis	0.000164	0.000329	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—PLG—atherosclerosis	0.000164	0.000328	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—CYBA—atherosclerosis	0.000163	0.000327	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—AGT—atherosclerosis	0.000162	0.000326	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—PIK3CG—atherosclerosis	0.000162	0.000324	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—CCL3—atherosclerosis	0.000161	0.000323	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—CD36—atherosclerosis	0.000161	0.000323	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—FABP4—atherosclerosis	0.00016	0.000321	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—LCAT—atherosclerosis	0.00016	0.000321	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—GHRL—atherosclerosis	0.00016	0.00032	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—PLAT—atherosclerosis	0.00016	0.00032	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—PARP1—atherosclerosis	0.00016	0.00032	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—APOA4—atherosclerosis	0.000157	0.000315	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—SOCS3—atherosclerosis	0.000155	0.000311	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—NCF1—atherosclerosis	0.000154	0.000309	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—CYP7A1—atherosclerosis	0.000154	0.000309	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—F2—atherosclerosis	0.000153	0.000308	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—MTHFR—atherosclerosis	0.000152	0.000306	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—F2—atherosclerosis	0.00015	0.000301	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—MMP3—atherosclerosis	0.00015	0.0003	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—PPARA—atherosclerosis	0.000149	0.0003	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—IGF2—atherosclerosis	0.000149	0.000299	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—AGT—atherosclerosis	0.000147	0.000296	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	0.000147	0.000295	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—PIK3CG—atherosclerosis	0.000147	0.000294	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—EDNRA—atherosclerosis	0.000145	0.000292	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—CCR2—atherosclerosis	0.000145	0.000292	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—CYBA—atherosclerosis	0.000145	0.000291	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—AGT—atherosclerosis	0.000145	0.000291	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—APOB—atherosclerosis	0.000145	0.00029	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—PIK3CG—atherosclerosis	0.000144	0.000288	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—CXCL8—atherosclerosis	0.000143	0.000288	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—CYP27A1—atherosclerosis	0.000142	0.000286	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—EDN1—atherosclerosis	0.000142	0.000285	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—APOE—atherosclerosis	0.000142	0.000285	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—GHRL—atherosclerosis	0.000142	0.000285	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—PARP1—atherosclerosis	0.000142	0.000285	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—PLAT—atherosclerosis	0.000142	0.000285	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—CCL5—atherosclerosis	0.000141	0.000283	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—CAV1—atherosclerosis	0.000141	0.000282	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—APOA1—atherosclerosis	0.00014	0.000281	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	0.00014	0.000281	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—KNG1—atherosclerosis	0.00014	0.000281	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—AGTR1—atherosclerosis	0.000139	0.00028	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—LPL—atherosclerosis	0.000138	0.000277	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	0.000137	0.000274	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—CCL2—atherosclerosis	0.000137	0.000274	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—F2—atherosclerosis	0.000136	0.000273	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—PLG—atherosclerosis	0.000136	0.000272	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—APOA2—atherosclerosis	0.000135	0.000271	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—ALOX15—atherosclerosis	0.000135	0.000271	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—ALOX5AP—atherosclerosis	0.000135	0.000271	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—PLA2G2A—atherosclerosis	0.000135	0.000271	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—PRKCG—atherosclerosis	0.000134	0.000269	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—ABCG5—atherosclerosis	0.000133	0.000268	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	0.000133	0.000267	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—SPP1—atherosclerosis	0.000131	0.000262	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—PIK3CG—atherosclerosis	0.00013	0.000262	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—CXCL8—atherosclerosis	0.00013	0.000261	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—LPA—atherosclerosis	0.000129	0.000258	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—SOCS3—atherosclerosis	0.000129	0.000258	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—PIK3CG—atherosclerosis	0.000128	0.000257	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—BGN—atherosclerosis	0.000125	0.00025	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—KNG1—atherosclerosis	0.000124	0.00025	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—MMP3—atherosclerosis	0.000124	0.000249	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	0.000124	0.000248	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—AGTR1—atherosclerosis	0.000124	0.000248	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—IGF2—atherosclerosis	0.000124	0.000248	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—PPARG—atherosclerosis	0.000124	0.000248	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—APOA5—atherosclerosis	0.000123	0.000248	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—CCL2—atherosclerosis	0.000121	0.000244	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—INS—atherosclerosis	0.000121	0.000243	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—PDGFB—atherosclerosis	0.000121	0.000243	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—PLG—atherosclerosis	0.000121	0.000242	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—APOB—atherosclerosis	0.00012	0.000241	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	0.00012	0.000241	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—CXCL8—atherosclerosis	0.000119	0.000239	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—PLA2G1B—atherosclerosis	0.000119	0.000238	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—AGT—atherosclerosis	0.000118	0.000237	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—EDN1—atherosclerosis	0.000118	0.000237	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	0.000117	0.000236	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—CCL5—atherosclerosis	0.000117	0.000235	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	0.000116	0.000234	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	0.000116	0.000233	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—APOE—atherosclerosis	0.000116	0.000232	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—LEP—atherosclerosis	0.000116	0.000232	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—ALOX5—atherosclerosis	0.000115	0.00023	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—CAV1—atherosclerosis	0.000115	0.00023	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—LPL—atherosclerosis	0.000115	0.00023	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—APOA1—atherosclerosis	0.000114	0.00023	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—SOCS3—atherosclerosis	0.000114	0.000229	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—PRKCG—atherosclerosis	0.000111	0.000224	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—ALB—atherosclerosis	0.000111	0.000223	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—ESR1—atherosclerosis	0.00011	0.000222	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—MMP3—atherosclerosis	0.00011	0.000221	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—IGF2—atherosclerosis	0.00011	0.00022	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—F2—atherosclerosis	0.000109	0.000219	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—SPP1—atherosclerosis	0.000109	0.000218	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—CXCL8—atherosclerosis	0.000108	0.000217	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—APOB—atherosclerosis	0.000107	0.000214	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—NOS3—atherosclerosis	0.000106	0.000213	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	0.000106	0.000213	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—CXCL8—atherosclerosis	0.000106	0.000212	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—EDN1—atherosclerosis	0.000105	0.00021	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—PIK3CG—atherosclerosis	0.000104	0.00021	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—CCL5—atherosclerosis	0.000104	0.000209	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—NAMPT—atherosclerosis	0.000103	0.000207	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	0.000102	0.000205	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—LIPC—atherosclerosis	0.000102	0.000205	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—LPL—atherosclerosis	0.000102	0.000204	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—APOC3—atherosclerosis	0.000102	0.000204	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—LDLR—atherosclerosis	0.000101	0.000203	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—PDGFB—atherosclerosis	0.0001	0.000201	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—MAPK3—atherosclerosis	0.0001	0.000201	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—PRKCG—atherosclerosis	9.89e-05	0.000199	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—INS—atherosclerosis	9.88e-05	0.000198	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—CETP—atherosclerosis	9.87e-05	0.000198	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—AGT—atherosclerosis	9.8e-05	0.000197	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—CCL2—atherosclerosis	9.73e-05	0.000195	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—PTGS2—atherosclerosis	9.72e-05	0.000195	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—SPP1—atherosclerosis	9.64e-05	0.000193	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—APOE—atherosclerosis	9.6e-05	0.000193	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—LEP—atherosclerosis	9.6e-05	0.000193	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—CXCL8—atherosclerosis	9.6e-05	0.000193	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—IGF1—atherosclerosis	9.56e-05	0.000192	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—CAV1—atherosclerosis	9.51e-05	0.000191	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—APOA1—atherosclerosis	9.49e-05	0.000191	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—SCARB1—atherosclerosis	9.45e-05	0.00019	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	9.2e-05	0.000185	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—ESR1—atherosclerosis	9.17e-05	0.000184	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—SERPINE1—atherosclerosis	9.08e-05	0.000182	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—F2—atherosclerosis	9.06e-05	0.000182	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—HMGCR—atherosclerosis	8.92e-05	0.000179	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—PDGFB—atherosclerosis	8.92e-05	0.000179	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—AGT—atherosclerosis	8.71e-05	0.000175	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—NOS3—atherosclerosis	8.67e-05	0.000174	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—PIK3CG—atherosclerosis	8.67e-05	0.000174	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—LEP—atherosclerosis	8.53e-05	0.000171	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—APOE—atherosclerosis	8.53e-05	0.000171	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—CAV1—atherosclerosis	8.45e-05	0.00017	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—APOA1—atherosclerosis	8.43e-05	0.000169	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—MAPK3—atherosclerosis	8.3e-05	0.000167	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—INS—atherosclerosis	8.2e-05	0.000165	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—ESR1—atherosclerosis	8.14e-05	0.000163	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—CCL2—atherosclerosis	8.07e-05	0.000162	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	8.05e-05	0.000162	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—F2—atherosclerosis	8.04e-05	0.000161	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—ABCA1—atherosclerosis	7.95e-05	0.00016	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—IGF1—atherosclerosis	7.94e-05	0.000159	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—PIK3CG—atherosclerosis	7.7e-05	0.000154	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—CXCL8—atherosclerosis	7.69e-05	0.000154	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—SERPINE1—atherosclerosis	7.54e-05	0.000151	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—AKT1—atherosclerosis	7.43e-05	0.000149	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—MAPK3—atherosclerosis	7.37e-05	0.000148	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—IL6—atherosclerosis	7.31e-05	0.000147	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—INS—atherosclerosis	7.29e-05	0.000146	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—NOS3—atherosclerosis	7.19e-05	0.000144	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—CCL2—atherosclerosis	7.17e-05	0.000144	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—IGF1—atherosclerosis	7.05e-05	0.000141	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—MMP9—atherosclerosis	6.95e-05	0.00014	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—NFKB1—atherosclerosis	6.88e-05	0.000138	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—HMOX1—atherosclerosis	6.82e-05	0.000137	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—MAPK8—atherosclerosis	6.76e-05	0.000136	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—AKT1—atherosclerosis	6.75e-05	0.000135	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—SERPINE1—atherosclerosis	6.69e-05	0.000134	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—APOB—atherosclerosis	6.54e-05	0.000131	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—NOS3—atherosclerosis	6.39e-05	0.000128	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—CXCL8—atherosclerosis	6.38e-05	0.000128	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—GSTM1—atherosclerosis	6.36e-05	0.000128	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—VEGFA—atherosclerosis	6.24e-05	0.000125	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—LPL—atherosclerosis	6.24e-05	0.000125	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—STAT3—atherosclerosis	6.18e-05	0.000124	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—AKT1—atherosclerosis	6.16e-05	0.000124	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—GPX1—atherosclerosis	6.09e-05	0.000122	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—IL6—atherosclerosis	6.07e-05	0.000122	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—CD36—atherosclerosis	5.93e-05	0.000119	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—MAPK3—atherosclerosis	5.91e-05	0.000119	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—MMP9—atherosclerosis	5.77e-05	0.000116	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—TGFB1—atherosclerosis	5.73e-05	0.000115	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—NFKB1—atherosclerosis	5.71e-05	0.000115	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—CXCL8—atherosclerosis	5.67e-05	0.000114	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—MTHFR—atherosclerosis	5.62e-05	0.000113	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—MAPK8—atherosclerosis	5.61e-05	0.000113	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—AKT1—atherosclerosis	5.6e-05	0.000112	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—PPARA—atherosclerosis	5.51e-05	0.000111	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—AKT1—atherosclerosis	5.48e-05	0.00011	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—IL6—atherosclerosis	5.39e-05	0.000108	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—AGT—atherosclerosis	5.34e-05	0.000107	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—APOE—atherosclerosis	5.23e-05	0.000105	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—CAV1—atherosclerosis	5.18e-05	0.000104	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—VEGFA—atherosclerosis	5.18e-05	0.000104	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—APOA1—atherosclerosis	5.17e-05	0.000104	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—STAT3—atherosclerosis	5.13e-05	0.000103	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—MMP9—atherosclerosis	5.13e-05	0.000103	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—NFKB1—atherosclerosis	5.07e-05	0.000102	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—MAPK8—atherosclerosis	4.99e-05	0.0001	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—AKT1—atherosclerosis	4.97e-05	9.98e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—MAPK3—atherosclerosis	4.9e-05	9.84e-05	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—AKT1—atherosclerosis	4.89e-05	9.8e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—TGFB1—atherosclerosis	4.76e-05	9.55e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—PIK3CG—atherosclerosis	4.72e-05	9.48e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—VEGFA—atherosclerosis	4.6e-05	9.24e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—STAT3—atherosclerosis	4.56e-05	9.15e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—PPARG—atherosclerosis	4.56e-05	9.15e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—INS—atherosclerosis	4.47e-05	8.97e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—MAPK3—atherosclerosis	4.36e-05	8.74e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—IL6—atherosclerosis	4.32e-05	8.67e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—TGFB1—atherosclerosis	4.23e-05	8.48e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—ALB—atherosclerosis	4.1e-05	8.22e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—AKT1—atherosclerosis	3.98e-05	8e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—NOS3—atherosclerosis	3.92e-05	7.87e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—PTGS2—atherosclerosis	3.59e-05	7.19e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—IL6—atherosclerosis	3.58e-05	7.19e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—AKT1—atherosclerosis	3.31e-05	6.64e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—IL6—atherosclerosis	3.18e-05	6.39e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—AKT1—atherosclerosis	2.94e-05	5.89e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—AKT1—atherosclerosis	1.8e-05	3.62e-05	CbGpPWpGaD
